Vaxart Inc (VXRT)
1.02
+0.08
(+7.98%)
USD |
NASDAQ |
May 16, 16:00
1.04
+0.02
(+1.96%)
After-Hours: 20:00
Vaxart Price to Book Value: 3.239 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 3.239 |
| May 15, 2024 | 3.000 |
| May 14, 2024 | 2.746 |
| May 13, 2024 | 2.604 |
| May 10, 2024 | 2.239 |
| May 09, 2024 | 2.323 |
| May 08, 2024 | 2.318 |
| May 07, 2024 | 2.345 |
| May 06, 2024 | 2.433 |
| May 03, 2024 | 2.314 |
| May 02, 2024 | 2.378 |
| May 01, 2024 | 2.225 |
| April 30, 2024 | 2.270 |
| April 29, 2024 | 2.265 |
| April 26, 2024 | 2.254 |
| April 25, 2024 | 2.091 |
| April 24, 2024 | 2.254 |
| April 23, 2024 | 2.367 |
| April 22, 2024 | 2.421 |
| April 19, 2024 | 2.399 |
| April 18, 2024 | 2.675 |
| April 17, 2024 | 2.750 |
| April 16, 2024 | 2.840 |
| April 15, 2024 | 2.887 |
| April 12, 2024 | 2.890 |
| Date | Value |
|---|---|
| April 11, 2024 | 3.296 |
| April 10, 2024 | 3.201 |
| April 09, 2024 | 3.296 |
| April 08, 2024 | 3.423 |
| April 05, 2024 | 3.423 |
| April 04, 2024 | 3.582 |
| April 03, 2024 | 3.899 |
| April 02, 2024 | 3.930 |
| April 01, 2024 | 4.121 |
| March 31, 2024 | |
| March 28, 2024 | 3.91 |
| March 27, 2024 | 3.88 |
| March 26, 2024 | 3.669 |
| March 25, 2024 | 3.700 |
| March 22, 2024 | 3.790 |
| March 21, 2024 | 3.700 |
| March 20, 2024 | 3.730 |
| March 19, 2024 | 3.489 |
| March 18, 2024 | 3.489 |
| March 15, 2024 | 3.248 |
| March 14, 2024 | 3.308 |
| March 13, 2024 | 3.399 |
| March 12, 2024 | 3.429 |
| March 11, 2024 | 3.459 |
| March 08, 2024 | 3.579 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2939
Minimum
Sep 26 2019
46.01
Maximum
Jul 14 2020
4.249
Average
3.164
Median
Aug 01 2022
Price to Book Value Benchmarks
| Novavax Inc | -- |
| aTyr Pharma Inc | 1.577 |
| Allogene Therapeutics Inc | 1.115 |
| AIM ImmunoTech Inc | 2.039 |
| Protalix BioTherapeutics Inc | 2.880 |
Price to Book Value Related Metrics
| PS Ratio | 14.48 |
| Price | 1.02 |
| Earnings Yield | -51.96% |
| Market Cap | 180.37M |